Are Amanita muscaria gummies what they say they are? Often, no. When US laboratories have tested gummies sold as Amanita or "muscimol" products, many contained no muscimol at all. Instead they held psilocin, a synthetic psilocybin analogue, kava compounds or even a prescription drug, none of them on the label. In 2024, Diamond Shruumz chocolate bars, cones and gummies were linked to 180 illnesses in 34 states and were recalled. This guide explains what independent tests have found inside these products, what happened in the recall, where US regulators now stand, and what you can and can't check before you buy.
Amanita muscaria gummies are an unregulated product with a poor testing record. The FDA's analysis of 22 Diamond Shruumz gummies found muscimol in none of them, but psilocin in 14 and pregabalin in 4 (FDA 2024). In Oregon, the two gummies labelled as Amanita muscaria extracts contained no ibotenic acid or muscimol but did contain psilocin and other tryptamines (Correia 2025). The 2024 outbreak led to 73 hospitalisations, 38 intensive-care admissions and two deaths (Rumph 2026). In December 2024 the FDA said Amanita muscaria and its compounds aren't authorised food ingredients, so gummies containing them are adulterated under US food law.
We don't sell gummies, chocolates or any other edible Amanita product, and we don't sell isolated muscimol. This article is general information about a product category, not a recommendation to use one. Amanita muscaria is toxic in large amounts, and if someone has eaten a gummy and is confused, very drowsy, agitated or having seizures, call emergency services or a poison centre straight away.
What Are Amanita Muscaria Gummies?
They're flavoured chewable sweets marketed as containing extract of Amanita muscaria, the red-and-white fly agaric, or its main active compound, muscimol. Most are sold in smoke and vape shops, at stores that sell hemp-derived cannabis products, and online. The marketing usually promises relaxation, better sleep or a "legal high", and often adds a dose in milligrams of mushroom or extract per gummy.
The market grew quickly after 2022. In April 2025, researchers reviewed the 13 most-visited US websites selling Amanita products and found gummies on 12 of them. Among products that stated an amount, gummies listed an average of 4,182 mg of Amanita muscaria per product, with a range of 2,000 to 8,000 mg. Some products also contained THCP or delta-9 THC (LoParco 2026). Public-health researchers have warned that this market grew with almost no oversight and called for a regulatory response (Leas 2024).
It's worth separating these from ordinary "mushroom gummies". Most gummies sold under that name contain functional mushrooms such as lion's mane, reishi or cordyceps, which aren't psychoactive. The problems described here concern gummies sold for their effects on the mind: Amanita and muscimol gummies, and the "microdosing" sweets sold next to them.
What Do Lab Tests Find Inside These Gummies?
Every independent analysis so far has found a gap between label and contents. The pattern is consistent: little or no muscimol, and other psychoactive substances that the label doesn't mention.
| Study | What was tested | Main findings |
|---|---|---|
| FDA, 2024 | 22 Diamond Shruumz gummies | No muscimol in any gummy; psilocin in 14, acetylpsilocin in 14, kavalactones in 11, pregabalin in 4; 6 negative for all tested compounds |
| Michienzi 2024 (Virginia) | 6 bags of "nootropic" mushroom gummies | 4 contained psilocybin or psilocin, Schedule I substances |
| Correia 2025 (Oregon) | 8 psychoactive mushroom gummies | The 2 labelled as Amanita extracts had no ibotenic acid or muscimol but contained psilocin and tryptamines; 7 of 8 had psilocin; one "psilocybin-free" product had psilocybin; one had undeclared THC |
| Katragunta 2025 | 14 gummies among 27 products | 11 gummies claimed Amanita extracts; muscimol and muscarine found but no ibotenic acid; one "no psilocybin" gummy contained psilocin and psilocybin |
The FDA's results are the most detailed. Muscimol did turn up in 9 of 22 Diamond Shruumz chocolate bars, 5 of 10 cones, and the raw ingredient used to make some products, but in none of the gummies. Across all product types, the agency also found acetylpsilocin (4-AcO-DMT, a synthetic relative of psilocybin), psilocin, pregabalin and three kava compounds. Even samples of the same flavour varied in what they contained (FDA 2024).
Why would a product sold as Amanita contain psilocin? Nobody has proved a single reason, but the economics are easy to see. Psilocybin is controlled in most of the US, while Amanita muscaria isn't scheduled federally. A product labelled as Amanita can be sold openly. If it produces the stronger, more familiar effects of a tryptamine, buyers may be more satisfied with it. The result is a product whose label tells you almost nothing about what you're taking.
What Happened in the 2024 Diamond Shruumz Recall?
In late spring 2024, US poison centres began reporting serious illness in people who had eaten Diamond Shruumz "microdosing" chocolate bars. The CDC and FDA opened a national investigation, and the company, Prophet Premium Blends, recalled all of its chocolate bars, infused cones and gummies in 2024 (FDA 2024).
By October 2024, investigators had counted 180 illnesses in 34 states. Of these, 73 people were hospitalised, 38 were admitted to intensive care and 29 needed a breathing tube, and two people died; the FDA listed three potentially associated deaths. Eating Diamond Shruumz bars, rather than other mushroom chocolates, was linked to eight times the odds of seizures and of intubation, and eating larger amounts made hospitalisation more likely (Rumph 2026). Reported symptoms included seizures, loss of consciousness, confusion, agitation, abnormal heart rate, high or low blood pressure, nausea and vomiting (FDA 2024).
One published case shows how this looked in hospital. A 17-year-old arrived confused, with dilated pupils, heavy salivation and muscle jerks that didn't respond to benzodiazepines. She was intubated to protect her airway and recovered within eight hours. She had eaten a Diamond Shruumz chocolate bar (Ebbens 2024).
Recalls also leak. Researchers monitored online sales before and after the recall. Two weeks after it began, 45 of 67 websites that had sold Diamond Shruumz were still marketing the products, and 15 of them completed test purchases (Mackey 2025). The FDA notes that the recalled products have a long shelf life, so anyone who still has some should throw them away (FDA 2024).
Are Amanita Muscaria Gummies Legal in the US?
It's complicated, and it depends on how they're sold. Amanita muscaria isn't listed under the federal Controlled Substances Act. But on December 18, 2024, the FDA told industry and consumers that Amanita muscaria, its extracts, and its compounds muscimol, ibotenic acid and muscarine aren't authorised for use in conventional food and don't meet the "generally recognised as safe" standard. Gummies are conventional food, so the FDA treats gummies containing these ingredients as adulterated (FDA 2024b).
Some states have gone further. Louisiana bans Amanita muscaria for human consumption, and other states have proposed restrictions. A gummy that contains undeclared psilocin is a different matter entirely: psilocin is a Schedule I substance, whatever the label says. Our guide to whether Amanita muscaria is legal in the US tracks the federal position and the state measures, including the FDA's later action on dietary supplements. Outside the US, rules vary widely; see how to check whether Amanita is legal where you live.
What Are the Side Effects of Amanita Gummies?
There are two sets of risks: those of Amanita itself, and those of whatever else is in the gummy. Muscimol and ibotenic acid act on the brain's GABA and glutamate receptors. In a US poison-centre series of 34 people who ate these mushrooms, the typical picture was stomach upset, agitation or excitement, and drowsiness or reduced consciousness, alone or in combination. Five of the 34 needed a breathing tube, and most people's symptoms lasted less than a day (Moss 2019). Our guide to Amanita muscaria side effects and interactions covers these in detail.
The undeclared substances add their own risks:
- Psilocin and acetylpsilocin cause hallucinations, anxiety and sometimes panic. They can also interact with antidepressants and other drugs that act on serotonin.
- Pregabalin is a prescription nerve-pain and anti-seizure drug. It causes drowsiness and dizziness and adds to the sedating effects of alcohol, opioids and benzodiazepines.
- Kavalactones, from the kava plant, are sedating too, and kava has been linked to rare cases of liver injury.
- THC or THCP, found undeclared in some products, adds intoxication and anxiety in people who aren't expecting it.
Because you can't know which of these a gummy contains, you also can't predict how it will combine with your medicines. Several sedating substances together can slow breathing. If you take antidepressants, benzodiazepines or sleep medication, read our article on Amanita muscaria with SSRIs and benzodiazepines, and talk to your doctor; our guide on how to talk to your doctor about Amanita may help.
Why Are Gummies a Particularly Risky Format?
Several features make edibles harder to use safely than plain dried mushroom or capsules, even before you consider mislabelling.
- You can't see what's inside. A dried cap can be recognised as a mushroom. A gummy is flavouring, sugar and gelatin or pectin, and its active content can't be judged by eye, smell or taste.
- Doses are hard to compare. Labels may give milligrams of "mushroom", of "extract" or of "muscimol", and these numbers mean very different things. A milligram figure for whole mushroom says little about the actual muscimol content.
- Batches vary. The FDA found different compounds in samples of the same flavour of the same brand (FDA 2024).
- Effects are delayed. Amanita usually takes 30 minutes to 2 hours to act. People who feel nothing at first and take another gummy can end up with a much larger dose. In the 2024 outbreak, eating more product was linked to more severe outcomes (Rumph 2026).
- They look like sweets. Children and pets can mistake them for ordinary candy. Keep any edible locked away; our pet safety guide explains what to do if an animal eats one.
Forensic toxicologists have started to see muscimol candies in their casework too. A 2026 Italian report described measuring muscimol in the post-mortem blood of a person who had used several drugs, including muscimol sweets. The authors noted there's still no published reference data for interpreting muscimol blood levels (Pirani 2026). That means doctors and coroners are often working without a baseline.
What Can You Check Before Buying a Gummy?
Honestly, not much, and that's the main point of this article. A label or a website can't show you what's inside a gummy, and the studies above show that labels have often been wrong. If you're looking at one anyway, these checks will at least rule out the worst products.
- A batch-specific lab report. Look for a certificate of analysis from an independent laboratory that matches the batch number printed on your pack. It should report muscimol and ibotenic acid in measured amounts and screen for psilocybin, psilocin, other tryptamines and cannabinoids. A generic report with no batch number proves little.
- A full ingredient list. Vague phrases such as "proprietary mushroom blend" or "nootropic complex" are a warning sign.
- Claims that are too good. Products promising strong psychedelic effects from Amanita, or those that say "no psilocybin" without a test to back it up, deserve suspicion. In two separate studies, gummies labelled psilocybin-free contained it (Correia 2025; Katragunta 2025).
- The company's identity. A real business address and a way to contact it are the minimum. If a product has been recalled, check the FDA's recall list before you buy that brand.
Even a product that passes all of these is still an unregulated food in the US, and the FDA considers it adulterated. Single-ingredient formats, where the only content is the dried mushroom itself, are easier to identify than a flavoured sweet. That's also why our Amanita myths article puts gummies at the bottom of the list when it comes to trusting a label.
What Should You Do if Someone Feels Unwell After a Gummy?
Treat it as a possible poisoning. Call emergency services if the person has a seizure, can't be woken, is breathing slowly or is very agitated. Otherwise, call a poison centre; in the US the Poison Help line is 1-800-222-1222. Keep the packaging, because the brand, batch number and any listed ingredients help doctors. Tell them how many gummies were eaten and when, and mention any medicines or alcohol taken too.
Don't try to make the person vomit, and don't give more of the product or other substances to "balance" the effects. Most people poisoned by muscimol-containing mushrooms recover with supportive hospital care, but the unknown extra ingredients in gummies make treatment harder to plan (Moss 2019; Rumph 2026).
Frequently Asked Questions
Are Amanita gummies safe?
Their safety can't be judged from the label. In independent tests, many gummies sold as Amanita contained no muscimol but did contain psilocin, synthetic tryptamines, kava compounds or the drug pregabalin. The 2024 Diamond Shruumz outbreak caused 73 hospitalisations and two deaths.
Do Amanita muscaria gummies contain psilocybin?
They shouldn't, but several have. The FDA found psilocin in 14 of 22 Diamond Shruumz gummies, and in Oregon the two gummies labelled as Amanita extracts contained psilocin instead of muscimol (FDA 2024; Correia 2025).
Were Diamond Shruumz gummies recalled?
Yes. All Diamond Shruumz chocolate bars, infused cones and gummies were recalled in 2024 after 180 illnesses in 34 states. The products have a long shelf life, so any left at home should be thrown away.
Are muscimol gummies legal?
Muscimol isn't a federally scheduled drug in the US, but in December 2024 the FDA said muscimol and Amanita muscaria aren't authorised food ingredients, so gummies containing them are adulterated under food law. Some states restrict them further.
Will an Amanita gummy show up on a drug test?
Standard drug tests don't look for muscimol. But gummies that secretly contain psilocin or THC could produce a positive result on tests that screen for those substances, which is another reason undeclared ingredients matter.
The Bottom Line
Amanita muscaria gummies sell a promise the lab results don't support. Tested products have often contained no muscimol, while hiding psilocin, synthetic tryptamines, kava or prescription drugs, and the 2024 Diamond Shruumz outbreak showed how serious the consequences can be. In the US, the FDA treats these gummies as adulterated food. If you're curious about Amanita, learn what muscimol is and what effects to expect before anything else. And if a product's contents can't be verified, the safest choice is not to take it.
Related Articles
- Is Amanita Muscaria Legal in the US? Federal Law and the States
- What Is Muscimol? The Compound Behind Amanita's Effects
- Amanita Muscaria Side Effects and Interactions
- Ibotenic Acid vs Muscimol
- Amanita Muscaria Myths, Debunked
Sources
- US Food and Drug Administration. Investigation of illnesses: Diamond Shruumz-brand chocolate bars, cones, and gummies (June 2024). Updated November 15, 2024. fda.gov
- US Food and Drug Administration. FDA alerts industry and consumers about the use of Amanita muscaria or its constituents in food. December 18, 2024. fda.gov
- Rumph JT, Winquist A, Troeschel AN, et al. Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024. MMWR Morb Mortal Wkly Rep. 2026;75(13):179-184. PubMed 41955162
- Michienzi A, Hamlin J, Farah R, Bazydlo L. Notes from the Field: Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms - Charlottesville, Virginia, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024;73(28):628-630. PubMed 39024197
- Correia MS, Gonzaga MJ, Temple C, Gerona RR. Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon. Clin Toxicol (Phila). 2025;63(4):261-266. PubMed 39977248
- Katragunta K, Avula B, Chittiboyina AG, Lata H, Khan IA. Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer Products. Int J Med Mushrooms. 2025;27(1):29-39. PubMed 39717916
- LoParco CR, Tillett KK, Rossheim ME, Okey SA, Berg CJ. Amanita Muscaria Mushrooms: An Online Retail Assessment of Branded Retailers, 2025. Subst Use Misuse. 2026:1-7. PubMed 42762199
- Mackey T, Nali M, Larsen MZ, Li Z, Li J, Yang J. Online Availability of Diamond Shruumz Before and After FDA Recall Initiation: Qualitative Assessment and Simulated Test Purchasing. J Med Internet Res. 2025;27:e64820. PubMed 40586741
- Ebbens EF, Williams SR, Bruccoleri RE, Frazier SB. Neurotoxicity associated with the medicinal mushroom product-Diamond Shruumz: A case report. Toxicol Rep. 2024;13:101748. PubMed 39386889
- Pirani F, Rossi F, Piva E, Garagnani M, Fais P, Pascali JP. Analytical determination of muscimol in post-mortem blood in a case of polydrug user. Forensic Sci Int. 2026;390:113159. PubMed 42858512
- Moss MJ, Hendrickson RG. Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002-2016. Clin Toxicol (Phila). 2019;57(2):99-103. PubMed 30073844
- Leas EC, Satybaldiyeva N, Kepner W, et al. Need for a Public Health Response to the Unregulated Sales of Amanita muscaria Mushrooms. Am J Prev Med. 2024;67(3):458-463. PubMed 38864780

